Menstrual reduction with extended use of combination oral contraceptive pills: Randomized controlled trial

Obstetrics and Gynecology

Volumn 98, Issue 5, 2001, Pages 771-778

  Miller, Leslie ^a   Notter, Katherine M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MENSTRUATION; MENSTRUATION DISORDER; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPOTTING; SYMPTOM; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; CONTRACEPTIVES, ORAL, COMBINED; DRUG ADMINISTRATION SCHEDULE; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; HUMANS; MENSTRUATION; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0034761608     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200111000-00011     Document Type: Article

References (26)

1. Hatcher R, Trussel J, Stewart F, Cates W, Stewart G, Guest F, et al. The essentials of contraception. In: Hatcher RA, Trussell J, Stewart F, Cates W Jr, Stewart GK, Guest F, et al, eds. Contraceptive technologies. 17th ed. New York: Ardent Media, Inc. 1998:212-3.
2. Thomas SL, Ellertson C. Nuisance or natural and healthy: Should menstruation be optional for women? Lancet 2000;355:922-4.
3. Kubba A, Guillebaud J, Anderson RA, MacGregor EA. Contraception. Lancet 2000;356:1913-9.
4. Loudon NB, Foxwell M, Potts DM, Guild AL, Short RV. Acceptability of an oral contraceptive that reduces the frequency of menstruation: The tri-cycle pill regimen. BMJ 1977;2:487-90.
5. Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Contraception 1987;35:199-205.
6. de Voogd WS. Postponement of withdrawal bleeding with a monophasic oral contraceptive containing desogestrel and ethinyl estradiol. Contraception 1991;44:107-12.
7. Kornaat H, Geerdink MH, Klitsie JW. The acceptance of a 7-week cycle with a modern low-dose oral contraceptive. Contraception 1992;45:119-27.
8. Cachrimanidou AC, Helberg D, Nilsson S, Waldenstrom U, Olsson SE, Sikstrom B. Long interval treatment regimen with a desogestrel containing oral contraceptive. Contraception 1993;48:205-15.
9. Cachrimanidou AC, Hellberg D, Nilsson S, von Schoulz B, Crona N, Siegbahn A. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive. Contraception 1994;50:153-65.
10. Kovacs G, Rusden J, Evans A. A trimonthly regimen for oral contraceptives. Br J Fam Plann 1994;19:274-5.
11. Coutinho EM, O'Dwyer E, Barbosa IC, Gu ZP, Shaaban MM, Aboul-Oyoon M, et al. Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route. Contraception 1995;51:355-8.
12. Sulak PJ, Cressman BE, Waldrop E, Holleman S, Kuehl TJ. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997;89:179-83.
13. Boyle CA. Management of menstrual migraine. Neurology. 1999;53(Suppl 1):S14-S18.
14. Kistner RW. Current status of the hormonal treatment of endometriosis. Clin Obstet Gynecol 1966;9:271-92.
15. Stubblefield PG. Menstrual impact of contraception. Am J Obstet Gynecol 1994;170:1513-22.
16. Hillard PJA. The patient's reaction to side effects of oral contraceptives. Am J Obstet Gynecol 1989;161:1412-5.
17. Suvisaari J, Lahteenmaki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception 1996;54:201-8.
18. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users, continuous use. Obstet Gynecol 2000;95:261-6.
19. Rosenberg MJ, Meyers A, Roy V. Efficacy, cycle control, and side effects of low and lower dose oral contraceptives: A randomized trial of 20 micrograms and 35 micrograms estrogen preparations. Contraception 1999;60:321-9.
20. Grace E, Emans SJ, Havens KK, Merola JL, Woods ER. Contraceptive compliance with a triphasic and a monophasic norethindrone containing oral contraceptive pill in a private adolescent practice. Adolesc Pediatr Gynecol 1994;7:29-33.
21. Schilling LH, Bolding OT, Chenault CB, Chong AP, Fleury F, Forest K, et al. Evaluation of the clinical performance of three triphasic oral contraceptives: A multi-center, randomized comparative trial. Am J Obstet Gynecol 1989;160:1264-8.
22. Schwartz JL, Creinin MD, Pymar HC. The trimonthly combination oral contraceptive regimen: Is it cost effective? Contraception 1999;60:263-7.
23. Kaunitz AM. Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol 1994;170(Part 2):1543-9.
24. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78:716-21.
25. den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception 1999;59:357-62.
26. Rutter W, Knight C, Vizzard J, Mira M, Abraham S. Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill. Med J Aust. 1988;149:417-9.